Loss of heterozygosity in clinical stage IB cervical carcinoma: relationship with clinical and histopathologic features.

[1]  D. Gerhard,et al.  Allelotyping of all chromosomal arms in invasive cervical cancer. , 1996, Oncogene.

[2]  D. Porteous,et al.  Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. , 1996, Cancer research.

[3]  G. Emilion,et al.  LOH at 3p correlates with a poor survival in oral squamous cell carcinoma. , 1996, British Journal of Cancer.

[4]  P. Wingo,et al.  Cancer statistics, 1996 , 1996, CA: a cancer journal for clinicians.

[5]  H. Klinger,et al.  Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status. , 1996, Cancer research.

[6]  A. Look,et al.  Significance of chromosome 1p loss of heterozygosity in neuroblastoma. , 1995, Cancer research.

[7]  T. Burke,et al.  Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. , 1995, Gynecologic oncology.

[8]  G. Hampton,et al.  Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. , 1995, Cancer research.

[9]  R. Chaganti,et al.  Genetic alterations at 5p15: a potential marker for progression of precancerous lesions of the uterine cervix. , 1995, Journal of the National Cancer Institute.

[10]  I. Tomlinson,et al.  Loss of heterozygosity on chromosome 11 q in breast cancer. , 1995, Journal of clinical pathology.

[11]  H. Caron,et al.  Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. , 1995, Medical and pediatric oncology.

[12]  C. Herrington,et al.  Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma. , 1995, British Journal of Cancer.

[13]  D. Thomas,et al.  Loss of heterozygosity for DNA polymorphisms mapping to chromosomes 10 and 17 and prognosis in patients with gliomas. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[14]  S. H. Lee,et al.  Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas. , 1995, Cancer genetics and cytogenetics.

[15]  Y. Ye,et al.  Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer. , 1994, Journal of the National Cancer Institute.

[16]  S. Leenstra,et al.  Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis. , 1994, British Journal of Cancer.

[17]  P. Rabbitts,et al.  PCR‐RFLP studies on chromosome 3p in formaldehyde‐fixed, paraffin‐embedded cervical cancer tissues , 1994, International journal of cancer.

[18]  R. Chaganti,et al.  Allelotype analysis of cervical carcinoma. , 1994, Cancer research.

[19]  H. Sasaki,et al.  Allelotype of endometrial carcinoma. , 1994, Cancer research.

[20]  Z. F. Liu,et al.  Allelic loss of chromosome 18q and prognosis in colorectal cancer. , 1994, The New England journal of medicine.

[21]  G. Hampton,et al.  Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  F. Bosch,et al.  Prognostic significance of the loss of heterozygosity of nm23‐h1 and p53 genes in human colorectal carcinomas , 1994, Cancer.

[23]  S. Baylin,et al.  Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. , 1994, Cancer research.

[24]  N. Breslow,et al.  Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. , 1994, Cancer research.

[25]  B. Ponder,et al.  Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients. , 1994, British Journal of Cancer.

[26]  Yusuke Nakamura,et al.  Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: Frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17p , 1994, Genes, chromosomes & cancer.

[27]  M. Duffy.  Cellular oncogenes and suppressor genes as prognostic markers in cancer. , 1993, Clinical biochemistry.

[28]  A. Knudson,et al.  Antioncogenes and human cancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Larsson,et al.  Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases. , 1993, Cancer research.

[30]  G. Mann,et al.  Loss of heterozygosity in malignant melanoma at loci on chromosomes 11 and 17 implicated in the pathogenesis of other cancers , 1993, Genes, chromosomes & cancer.

[31]  M. Oshimura,et al.  Deletion mapping of chromosome 3p in human uterine cervical cancer. , 1993, Oncogene.

[32]  S. Korsmeyer,et al.  Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. , 1993, Blood.

[33]  E. Atkinson,et al.  Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients. , 1993, Gynecologic Oncology.

[34]  J. Ragoussis,et al.  Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. , 1993, British Journal of Cancer.

[35]  C. Bird,et al.  Cervical carcinoma: low frequency of allele loss at loci implicated in other common malignancies. , 1993, British Journal of Cancer.

[36]  Å. Borg,et al.  Chromosome I alterations in breast cancer: Allelic loss on Ip and Iq Is related to lymphogenic metastases and poor prognosis , 1992 .

[37]  Y. Nakamura,et al.  Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers. , 1992, Cancer research.

[38]  D. Shibata,et al.  Specific genetic analysis of microscopic tissue after selective ultraviolet radiation fractionation and the polymerase chain reaction. , 1992, The American journal of pathology.

[39]  B. Boman,et al.  A study of chromosome 6 allele loss in human colorectal carcinomas. , 1992, Anticancer research.

[40]  M. Chan,et al.  Genetic lesion in the carcinogenesis of cervical cancer. , 1992, Anticancer research.

[41]  Y. Nakamura,et al.  Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphisms. , 1992, Oncogene.

[42]  H. Klinger,et al.  Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomas , 1992, The Lancet.

[43]  A. Ayhan,et al.  Prognostic value of mitotic activity, eosinophilic and inflammatory reaction in stage I cancer of the uterine cervix. , 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[44]  R. Zaino,et al.  Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix a gynecologic oncology group study , 1992, Cancer.

[45]  D. Eccles,et al.  Allele loss on chromosome 11p is associated with poor survival in ovarian cancer. , 1992, Disease markers.

[46]  I. Bièche,et al.  Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer , 1992, The Lancet.

[47]  H. Nakano,et al.  Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy , 1992, Cancer.

[48]  H. Hausen.  Viruses in human cancers , 1991 .

[49]  B. C. Misra,et al.  Loss of heterozygosity for alleles on chromosome II in cervical carcinoma. , 1991, American journal of human genetics.

[50]  G. Yiu,et al.  Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma. , 1991, Cancer genetics and cytogenetics.

[51]  D. Gerhard,et al.  Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1. , 1990, Cancer research.

[52]  S. Syrjänen,et al.  Epidemiology of human papilloma virus infections and genital neoplasia. , 1990, Scandinavian journal of infectious diseases. Supplementum.

[53]  J. Yokota,et al.  Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. , 1989, Cancer research.

[54]  D. Mutch,et al.  Small‐Cell Undifferentiated Carcinoma of the Cervix: A Clinicopathologic, Ultrastructural, and Immunocytochemical Study of 15 Cases , 1988, The American journal of surgical pathology.

[55]  P. Grigsby,et al.  Adenocarcinoma of the uterine cervix: lack of evidence for a poor prognosis. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[56]  F. Hecht,et al.  Regional chromosome localization of human papillomavirus integration sites near fragile sites, oncogenes, and cancer chromosome breakpoints. , 1988, Cancer genetics and cytogenetics.

[57]  H. Brauch,et al.  Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma , 1988, Nature.

[58]  M Terada,et al.  Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Minna,et al.  Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer , 1987, Nature.

[60]  P. Saigo,et al.  Prognostic factors in adenocarcinoma of the uterine cervix , 1986, Cancer.

[61]  Takeomi Inoue.  Prognostic significance of the depth of invasion relating to nodal metastases, parametrial extension, and cell types: A study of 628 cases with stage IB, IIA, and IIB cervical carcinoma , 1984, Cancer.

[62]  T. Inoue,et al.  Prognostic significance of parametrial extension in patients with cervical carcinoma stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiation , 1984, Cancer.

[63]  M. Rotman,et al.  Vascular invasion in stage I carcinoma of the cervix , 1984, Cancer.

[64]  T. Iversen,et al.  Stage IB Carcinoma of the Cervix, The Norwegian Radium Hospital. II. Results when Pelvic Nodes Are Involved , 1982, Obstetrics and gynecology.

[65]  R. Mortel,et al.  Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix. , 1980, American journal of obstetrics and gynecology.

[66]  J. Parker,et al.  The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer , 1978, Cancer.

[67]  J. Parker,et al.  The prognostic significance of cell type and lesion size in patients with cervical cancer treated by radical surgery. , 1977, Gynecologic Oncology.

[68]  M. Piver,et al.  Prognostic Significance of Cervical Lesion Size and Pelvic Node Metastases in Cervical Carcinoma , 1975, Obstetrics and gynecology.

[69]  O. D. Chapman,et al.  Oral Lesions Associated with Dietary Deficiencies in Monkeys , 1941 .